Introduction of CT26.WT Line

The CT26.WT cell line, derived from a N-nitroso-N-methylurethane (NNMU)-induced undifferentiated colon carcinoma in BALB/c mice, is particularly valuable due to its ability to closely mimic the biological behavior of human colon cancer. CT26.WT cells are epithelial in nature and exhibit rapid proliferation, making them ideal candidates for in vivo and in vitro studies. The "WT" in CT26.WT stands for "wild type," highlighting its status as a standard reference model without any genetic modifications. This cell line is a well-established murine colon carcinoma model for studying the immune interactions and responses of colorectal cancer, especially in the context of syngeneic models using BALB/c mice. Additionally, it is widely employed in cancer research, particularly for studying tumor cell proliferation and the efficacy of anti-cancer agents.

Comprehensive CT26.WT-Based Proliferation Assay Services

At Creative Biolabs, a leading biotech company specializing in antibody development and cancer research, we offer comprehensive CT26.WT-based proliferation assays tailored to your research needs. Leveraging our extensive expertise in oncology and cell biology, we utilize a variety of cutting-edge technologies and methods to ensure precise and reliable results. These include MTT and WST-1 assays for cellular metabolic activity, BrdU incorporation assays for DNA synthesis, and various flow cytometry techniques to analyze cell cycle progression and proliferation indices. These methods ensure precise quantification of cell growth and viability, enabling a thorough evaluation of anti-cancer agents and therapeutic strategies. With a team of experienced experts and state-of-the-art facilities, Creative Biolabs ensures high-quality results and insightful analysis, aiding in the acceleration of your cancer research projects.

Service Workflow

At Creative Biolabs, our CT26.WT-based proliferation assay services follow a detailed and systematic workflow to ensure accuracy and reliability in your research outcomes. The process begins with an initial consultation to understand the specific needs of your project. Once we have gathered all information and materials from the client, our team of experts cultures the CT26.WT cells under optimized conditions. These cells are then treated with test compounds or control agents to assess their proliferative response. Using advanced technologies such as cell viability assays (e.g., MTT, XTT, or WST-1) and flow cytometry, we monitor cell proliferation. Data is then analyzed to provide comprehensive insights into the effects of the test conditions on cell growth. Ultimately, we deliver a detailed report summarizing our results, complete with graphical representations and statistical analyses.

Frequently Asked Questions

1. What is the turnaround time for a CT26.WT-based proliferation assay?

The turnaround time typically ranges from 3 to 5 weeks, depending on the complexity of the assay and the specific requirements of your study.

2. What is the price associated with the CT26.WT-based proliferation assay?

The price varies depending on the specific requirements and scope of the project. For a customized quote, please reach out to us.

3. Can the CT26.WT-based proliferation assay be customized to meet specific research needs?

Absolutely. We offer customized CT26.WT-based proliferation assays to meet your specific research needs and experimental designs.

Whether you are in the early stages of drug discovery or advancing toward clinical trials, our support will provide the robust data needed to make informed decisions. Contact us today to discuss how we help you achieve your research goals!

For Research Use Only | Not For Clinical Use